Complete resection of undifferentiated cardiac sarcoma and reconstruction of the atria and the superior vena cava: case report by Nobuyuki Furukawa et al.
Furukawa et al. Journal of Cardiothoracic Surgery 2012, 7:96
http://www.cardiothoracicsurgery.org/content/7/1/96CASE REPORT Open AccessComplete resection of undifferentiated cardiac
sarcoma and reconstruction of the atria and the
superior vena cava: case report
Nobuyuki Furukawa*, Jan Gummert and Jochen BörgermannAbstract
Primary cardiac tumors are rare with an incidence ranging from 0.001% to 0.03% in autopsy series. The prognosis of
cardiac sarcomas remains poor because it proliferates rapidly and distant metastases are often found at diagnosis.
A 47-year-old male complained of persistent cough. The chest roentgenogram was normal. Subsequent computed
tomography revealed a mass in the right atrium. Echocardiography and magnetic resonance imaging confirmed
also a right atrial mass (34 x 35 mm) infiltrating the atrial septum. The tumor was completely resected en bloc,
including the anterior and lateral right atrial walls, the left atrial dome, and a large segment of the superior vena
cava, and reconstructed the atria and superior vena cava with bovine pericardium. The tumor was histologically and
immunohistochemically diagnosed as undifferentiated pleomorphic sarcoma. This type of cardiac sarcoma is very
rare and usually found in the left atrium. Twenty-seven months after surgery, the patient is doing well without
metastasis or local tumor recurrence.
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Primary cardiac tumors are uncommon (incidence in
autopsy series, 0.001–0.03%). Among them, malignant
neoplasms account for <25% [1]. The prognosis of car-
diac sarcomas remains poor. Although a more effective
therapy would be desirable, complete resection is the
current standard treatment in cases without metastases.
We describe a case of undifferentiated pleomorphic sar-
coma infiltrating both atria and the superior vena cava.
We removed the tumor completely, including the sinus
node, by en bloc resection and reconstructed the atria
and superior vena cava with bovine pericardium.Case Presentation
A 47-year-old male complained of persistent cough. La-
boratory tests showed a high CRP level and an elevated
erythrocyte sedimentation rate. The patient had a medical
history of thalassemia minor and mild anemia but was not
taking any medication. Physical examination and chest
roentgenogram were unremarkable. Electrocardiography* Correspondence: qtgkk994@yahoo.co.jp
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reproduction in any medium, provided the orrevealed sinus rhythm and incomplete right bundle
branch block. Subsequent computed tomography demon-
strated a right atrial mass, but no other anomalies. Echo-
cardiography and magnetic resonance imaging confirmed
a right atrial mass (34 × 35 mm) suspicious for a malig-
nant cardiac tumor infiltrating the atrial septum (Figure 1).
The tricuspid valve was intact; right atrial and ventricular
sizes were normal; and left ventricular function was good.
The patient was referred to our institution for treat-
ment. The heart was exposed via mid-sternotomy. Be-
cause of severe narrowing from the tumor, the superior
vena cava was unsuitable as a cannulation site. After full
heparinization and flooding of the surgical field with
CO2, the ascending aorta, inferior vena cava, and the in-
nominate vein were cannulated. Cardiopulmonary by-
pass was commenced after the target ACT ≥ 450s was
reached. A vent was placed into the left ventricle. Ex-
ploration revealed that the tumor was penetrating the
walls of the right atrium and of the superior vena cava
(Figure 2 A). On complete bypass, the ascending aorta
was crossclamped and multiple doses of warm blood
Calafiore cardioplegic solution were instilled via the aor-
tic root. The tumor was resected en bloc, including theral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Cardiac magnetic resonance imaging demonstrating a
mass in the right atrium involving the left atrial dome and
atrial septum.
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thirds of the right atrium altogether), the left atrial dome,
and a large segment of the proximal superior vena cava
(Figure 2 B). The atrial septum was found to be free. The
left atrial roof was reconstructed with a patch of bovine
pericardium (Figure 2C) secured with running 4–0 pro-
lene (Ethicon, Norderstedt, Germany). The right atriumFigure 2 Intraoperative view. Note that the tumor extends into an throu
Complete tumor removal by en bloc resection, including the right atrial an
superior vena cava (B). Repair of the left atrial dome (C). Reconstruction ofand the superior vena cava were each reconstructed with
a folded strip of bovine pericardium, again using running
4–0 prolene suture, making sure that the neo-right atrial
dome provided sufficient reservoir capacity (Figure 2D).
The preliminary histologic evaluation revealed clear mar-
gins. The aortic clamp was removed after careful de-
airing. As expected, the heart was beating in a nodal
escape rhythm because the sinus node had been removed.
We therefore secured permanent bipolar epicardial pace-
maker leads to the remaining right atrium and to the left
ventricle. The leads were brought out through the inner
layers of the thoracic wall and connected to a DDD pace-
maker which was implanted in the left pectoral area.
Under mild inotropic support, the patient was easily
weaned from cardiopulmonary bypass. All cannulas were
removed and the cannulation sites oversewn. Protamin
was administered. The pericardium was loosely approxi-
mated over a drain. The wound was closed in layers after
careful hemostasis. The patient was transferred to the in-
tensive care unit in stable condition.
The patient recovered without complications, was dis-
charged home on postoperative day 7 and referred to
undergo local radiotherapy and systemic chemotherapy
with ifosfamide and paclitaxel. For a duration of three
months, the patient was anticoagulated with warfarin
and then switched to oral acetyl salicylic acid. Thirty-five
months after surgery, the patient is doing well and
remains free of metastases or local tumor recurrence.
Histological examination (Figure 3) revealed dense
groups of polygonal and spindle cells with eosinophilicgh the wall of the superior vena cava and the left atrial dome (A).
terior and lateral wall, left atrial dome, and a large segment of the
the right atrium and superior vena cava with bovine pericardium (D).
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ity chromatin and irregular nucleoli. On immunohisto-
chemical examination, the neoplastic cells stained
positive for vimentin but negative for pan-keratin, des-
min, actin, and histiocyte markers. These observations
are compatible with a histological diagnosis of undiffer-
entiated pleomorphic sarcoma.
Discussion
Primary cardiac tumors are uncommon. Approximately
three fourth of them are malignant [1]. Sarcomas com-
prise two-thirds of these malignancies [2]. Cardiac sarco-
mas include angiosarcoma; sarcoma with myofibroblastic
differentiation; synovial sarcoma; and rhabdomyosarcoma.
Sarcomas with myofibroblastic differentiation are the
most diverse types, subclassified as undifferentiated pleo-
morphic sarcoma; osteosarcoma; leiomyosarcoma; and
fibrosarcoma [3]. In several large series [4,5], the most
common type was angiosarcoma, while undifferentiated
pleomorphic sarcomas were relatively rare (only 6–7%).
Undifferentiated pleomorphic sarcoma is usually found in
the left atrium and exhibits a solid and infiltrative pattern.
As described here, undifferentiated pleomorphic sarcoma
with bilateral involvement is very rare [6].
The prognosis of patients with cardiac sarcoma is poor
because the tumor proliferates rapidly and distant me-
tastases are often found at the time of the initial diagno-
sis. Hamidi et al. reported that the median survival of
patients who underwent surgery was 12 months,
whereas survival of patients not operated upon was only
1 month [1]. Simpson et al. reported that the median
survival of patients with and without metastasis was 5
and 15 months, respectively [4].
In our case, the tumor infiltrated the left atrium and
approximately two-thirds of the right atrium, involving
the sinus node and superior vena cava. Fortunately, this
infiltration was relatively anterior in the left atrial dome,
facilitating complete resection and repair with bovine
pericardium. When the tumor infiltrates the left atriumFigure 3 Cut surface of the lesion showing the pale yellow and solid
coagulated blood. (A) An HE-stained microscopic section reveals dense g
large pleomorphic nuclei with high density chromatin and irregular nucleomore deeply and to a greater extent, resection and
reconstruction is relatively difficult. In such cases, auto-
transplantation is an option permitting complete resec-
tion and repair [2,7].
Cardiac sarcomas are often asymptomatic. In advanced
cases, they occasionally produce nonspecific symptoms.
Malignant cardiac tumors with direct invasion of the
pericardium can cause pericardial effusion or arrhyth-
mias, such as atrial fibrillation, heart block, or recurrent
ventricular tachycardia [2,3]. We performed en-bloc re-
section of the tumor, including the sinus node. Simultan-
eously, permanent epicardial pacemaker leads were
placed onto the remaining right atrium and onto the left
ventricle. Radical resection of the tumor is difficult or
impossible if the tumor infiltrates the conduction system
[8]. In many cases, cardiac sarcoma is so widespread that
only palliative surgery can be performed [8]. It remains
unclear if there is an alternative to radical surgical resec-
tion in patients without metastatic disease. Because car-
diac sarcoma is uncommon and because there are only a
few limited studies on the subject, no standard treat-
ment has been defined. Although aggressive resection of
cardiac sarcoma is challenging, some studies clearly
demonstrate that complete tumor removal is the best
method for improving survival [1,2,4].
In our case, chemotherapy and radiotherapy were
initiated relatively early after surgery, especially in view
of reports [2,7] of local recurrences or distant metastases
several years after successful resection. The effectiveness
of such adjuvant therapies for cardiac sarcoma remains
controversial. However, studies [1,2] have shown that
combining several carcinostatics is more effective than
single-agent therapy, and that postoperative radiotherapy
can improve survival.
Conclusion
We presented a rare case of undifferentiated pleo-
morphic cardiac sarcoma successfully removed by en-
bloc resection which included two-thirds of the rightpart of the tumor and the cystic component which is filled with
roups of polygonal and spindle cells with eosinophilic cytoplasm and
li (B).
Furukawa et al. Journal of Cardiothoracic Surgery 2012, 7:96 Page 4 of 4
http://www.cardiothoracicsurgery.org/content/7/1/96atrium, the left atrial dome and a large segment of the
superior vena cava, reconstructing the defects with bo-
vine pericardium. Despite successful management, close
follow-up is mandatory because of the overall poor prog-
nosis of cardiac sarcoma.
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